Trade Ascendis Pharma A/S - ASND CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.88
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.02246 %(-$0.45)Trade size with leverage ~ $2,000.00Money from leverage ~ $$1,000.00Go to platform: -0.02246%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position0.00023 %($0.00)Trade size with leverage ~ $2,000.00Money from leverage ~ $$1,000.00Go to platform: 0.00023%
• Overnight funding adjustment time: 22:00 (UTC)
• Currency: USD
• Min traded quantity: 0.1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.02246 %
  (-$0.45)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: 0.00023 %
  ($0.00)

Key Stats

• Prev. Close: 249.76
• Open: 250.66
• 1-Year Change: 25.15%
• Day's Range: 248.11 - 257.59

Trade Ascendis Pharma A/S - ASND

Ascendis Pharma A/S (NASDAQ: ASND) is a Danish biopharmaceutical company developing long-acting prodrug therapies using its TransCon™ platform. Its approved product, Skytrofa, targets growth hormone deficiency, while its pipeline includes endocrinology and oncology assets. Ascendis is a high-profile biotech growth name with late-stage catalysts and commercial ramp-up underway.